HealthDay News — Menopausal hormone therapy (HT) usage rates declined from 2007 to 2023 and remain low, according to a study presented at the annual meeting of The Menopause Society, held from ...

Ojji, PhD, from the University of Abuja in Nigeria, and colleagues compared the effectiveness and safety of a novel low-dose triple-pill protocol with a standard-care protocol for lowering blood ...

However, omission does result in reductions in neutropenia, thrombocytopenia, and use of granulocyte colony-stimulating factor ...

Users take hearing tests on iPhones or iPads running iOS 18, and then their AirPods make "personalized dynamic adjustments" to allow them to hear.

Veligrotug is an investigational monoclonal antibody that inhibits the activity of insulin-like growth factor-1 receptor.

The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to plozasiran for use as an adjunct to diet to reduce triglycerides in adults with familial chylomicronemia syndrome ...

HealthDay News — Contraindicated drug pairs are uncommon in youth with Medicaid coverage filling combinations of behavioral and mental health (BMH) medications, according to a study published online ...

Second study reveals prevalence of 8.7% for elevated BP, 5.4% for hypertension among youth aged 8 to 19 years.

HealthDay News — A case of bird flu has been confirmed in a Missouri resident who had no known contact with dairy cows, poultry or wild birds, US health officials report.

In a statement, the ERISA Industry Committee, which represents major employers, warned that some of the rules are "so burdensome that many of our members will have no other choice but to re-think the ...

The ultra-long acting investigational biologic is administered once every 6 months as a subcutaneous injection. Depemokimab reduced the rate of exacerbations in patients with severe asthma with type 2 ...

Researchers say the data indicate cancer cases continued to be underdiagnosed in the second year of the pandemic ...